Research workbench
AlphaFold monomer V2.0 prediction for ribosomal lysine N-methyltransferase 5 (B3LT98)
Analyse AlphaFold monomer V2.0 prediction for ribosomal lysine N-methyltransferase 5… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- Accession
- B3LT98
- Type
- protein
- Length
- 367 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x0D671490EE06E75975e90D7F99F73B20BE618744
- Molecule
- Ribosomal lysine N-methyltransferase 5
- UniProt
- B3LT98
- Pockets
- 1 · best druggability 0.71
Structure
1 distinct chain · 31% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ribosomal lysine N-methyltransferase 5 | protein | 367 | 31% helix, 22% strand | B3LT98 |
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 53 | 0.71 | 0.99 | 23 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt B3LT98
- Elsewhere: UniProt B3LT98 · AlphaFold DB B3LT98
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.